There’s been a rising concern with clinical trial fraud and misconduct, particularly over the number of “zombie” trials that have been discovered in recent years — that is, trials in which a portion of the data is either invented out of whole cloth or is manipulated to the point of dishonesty. Researchers should expect greater scrutiny from both sponsors and regulators and should make sure their data integrity plans are solid to catch any bad actors before they can irreparably tarnish a study.